Group 5F: Lobular Breast Cancer; Predictive Biomarkers

Name: Group 5F: Lobular Breast Cancer; Predictive Biomarkers
Start: 2023-12-15
End: 2023-12-15

Poster #PO5-06-14: Genomic landscape and clinical outcomes of triple-negative invasive lobular carcinoma.

Poster #PO4-14-12: Predicting response to HER2 tyrosine kinase inhibitors and antibody drug conjugates in HER2 mutant invasive lobular carcinoma using CRISPR/Cas9 knock-in cell lines and patient-derived organoids.